Vimarsana
Biggest News Aggregation in the World

Ken Herrmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ken Herrmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ken Herrmann Today - Breaking & Trending Today

Senior Pickleball Pros Get The Spotlight At The APP US Champions Cup - Vimarsana News

Senior Pickleball Pros Get The Spotlight At The APP US Champions Cup

The APP headed to the legendary Pictonia at Holly Hills for the 75,000 US Champions cup and awarded 75,000 of prize money to the strongest field of seniors ever put together.

Source: forbes.com
Pickleball players prepare for 2024 AARP US Champions Cup - Vimarsana News

Pickleball players prepare for 2024 AARP US Champions Cup

Pickleball players from Florida and throughout the country are in Volusia County for the launch of an exclusive competition for players 40 and above.

Lots Of First Time Winners At The Association Of Pickleball Players 2024 Punta Gorda Open - Vimarsana News

Lots Of First Time Winners At The Association Of Pickleball Players 2024 Punta Gorda Open

The Association of Pickleball Players (APP) kicked off its 2024 season with new rules, new competition format, and a ton of new winners in Punta Gorda

Source: forbes.com
Northbrook Park Districts expands indoor, outdoor pickleball programs - Vimarsana News

Northbrook Park Districts expands indoor, outdoor pickleball programs

In the five years since the Northbrook Park District began offering pickleball, the program has grown tremendously in the wake of the sport's boom in popularity, both locally and across the country.

AdvanCell reaches milestone as first prostate cancer patient dosed with 212Pb-ADVC001 - Vimarsana News

AdvanCell reaches milestone as first prostate cancer patient dosed with 212Pb-ADVC001

AdvanCell, a radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for cancer patients, today announced the first patient was treated with 212Pb-ADVC001, a Targeted Alpha Therapy in development for the treatment of PSMA-positive metastatic Castration-Resistant Prostate Cancer (mCRPC).